NVS - Novartis to buy autoimmune drug developer Calypso Biotech
2024-01-08 11:54:11 ET
More on Novartis
- Novartis: Post Investor Day, Higher Guidance Priced In
- Novartis AG (NVS) 10th Annual ESG Investor Event Conference (Transcript)
- Sandoz Group: Novartis Spinoff With A Double-Digit EBITDA CAGR Through 2028
- Alphabet unit inks deals with Eli Lilly and Novartis for AI drug discovery
- Novartis gets FDA approval for new Pluvicto manufacturing plant
For further details see:
Novartis to buy autoimmune drug developer Calypso Biotech